Correvio Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Correvio Pharma (CORV) Misses Q1 EPS by 3c, Revenues Miss
May 8, 2019 8:10 AM EDTCorrevio Pharma (NASDAQ: CORV) reported Q1 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $7.89 million.
"2019 is off to a strong start with first quarter revenues up 16% year-over-year in local... More



